US Archives - Page 73 of 112 - European Medical Journal

Genomic Testing Guides Chemotherapy Choices in Breast Cancer: SABCS 2024

In this study, patients with a recurrence scores greater than 31 exhibited significant improvements in survival outcomes when treated with taxane and anthracycline-based chemotherapy.

AI Technology Offers Hope for Faster Diagnosis of Infantile Spasms: AES 2024

AI-powered video analysis could transform the diagnosis of infantile spasms, a severe form of epilepsy in babies, by enabling early detection and treatment, according to new research.

Tamoxifen Reduces Recurrence for Patients with 'Good-Risk' Ductal Carcinoma In Situ: SABCS 2024

Findings, presented at SABCS 2024, support tamoxifen as an effective adjuvant therapy for reducing recurrence in women with “good-risk” DCIS who opt to skip RT.

Lessons from HIV/AIDS and COVID-19

The global challenges posed by HIV/AIDS and COVID-19 provide critical insights for managing future infectious disease outbreaks, according to a recent study by Anthony S Fauci and Gregory K Folkers.

Thin Melanomas: A Critical 0.8 mm Threshold

A recent cohort study involving 144,447 participants has found a crucial threshold in melanoma risk for tumors with a Breslow thickness between 0.8 and 1.0 mm.

A Guide to Chronic Hand Eczema

Chronic Hand Eczema (CHE) is a condition that can go under-recognized despite its significant impact on patients. With l.imited guidance..

EMJ

Prof Yoshiya Tanaka

Consultant Rheumatologist; Chairman, First Department of Internal Medicine; Dean, Graduate School of Medical Science, University of…

EMJ

Dr Judith A. Smith

Pediatric Rheumatologist; Associate Professor, Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, University of…

EMJ

Dr Isabelle Amigues

CEO, UnabridgedMD, Denver, Colorado, USA…

EMJ

Dr Arthur Kavanagh

Rheumatologist; Professor of Medicine; Director, Center for Innovative Therapy, Division of Rheumatology, Allergy and Immunology…